BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24853694)

  • 1. A survey of the practice patterns of gynecologic oncologists dealing with hereditary cancer patients in Japan.
    Tanabe N; Shikama A; Bando H; Satoh T; Shimizu C
    Fam Cancer; 2014 Sep; 13(3):489-98. PubMed ID: 24853694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO).
    Kobayashi Y; Masuda K; Hiraswa A; Takehara K; Tsuda H; Watanabe Y; Oda K; Nagase S; Mandai M; Okamoto A; Yaegashi N; Mikami M; Enomoto T; Aoki D; Katabuchi H;
    J Gynecol Oncol; 2022 Sep; 33(5):e61. PubMed ID: 35882604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.
    Newcomb LK; Toal CT; Rindos NB; Wang L; Mansuria SM
    J Minim Invasive Gynecol; 2020; 27(7):1511-1515. PubMed ID: 31927044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice Patterns of Hereditary Ovarian Cancer Management in Korea.
    Choi MC; Lim MC; Lee M; Kim MK; Suh DH; Song YJ; Kim TJ; Chang SJ; Kim JW
    Int J Gynecol Cancer; 2017 Jun; 27(5):895-899. PubMed ID: 28498247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
    Arai M; Iwase T; Takazawa Y; Takeshima N
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].
    Arai M; Taki K; Iwase H; Takizawa K; Nishimura S; Iwase T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):525-31. PubMed ID: 22504676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan.
    Bando H; Kataoka A; Tamaki K; Kobayashi M; Tamura N; Ozawa M; Kawano J; Fukatsu Y; Kitano A; Shiota K; Yamauchi H
    Breast Cancer; 2020 Sep; 27(5):796-802. PubMed ID: 32592140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
    Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
    J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology, on a fact-finding questionnaire on the status of treatment of hereditary breast and ovarian cancer syndrome in Japan.
    Satoh T; Takamatsu K; Takeshima N; Kobayashi H; Aoki D; Suzuki N
    J Obstet Gynaecol Res; 2017 Sep; 43(9):1377-1380. PubMed ID: 28833906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A report on the 73th Annual Congress of the Japan Society of Obstetrics and Gynecology International Workshop for Junior Fellows: Risk-reducing surgery for hereditary breast and ovarian cancer.
    Hirayama T; Inayama Y; Odajima S; Yamanaka A; Sekine M; Terao Y; Koide K; Kuwabara Y; Yahata H; Yanaihara N; Nagase S; Kobayashi Y; Sekizawa A
    J Obstet Gynaecol Res; 2021 Nov; 47(11):3761-3766. PubMed ID: 34333832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
    Eliade M; Skrzypski J; Baurand A; Jacquot C; Bertolone G; Loustalot C; Coutant C; Guy F; Fumoleau P; Duffourd Y; Arnould L; Delignette A; Padéano MM; Lepage C; Raichon-Patru G; Boudrant A; Bône-Lépinoy MC; Villing AL; Charpin A; Peignaux K; Chevrier S; Vegran F; Ghiringhelli F; Boidot R; Sevenet N; Lizard S; Faivre L
    Oncotarget; 2017 Jan; 8(2):1957-1971. PubMed ID: 27779110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists.
    Cmelak AJ; Choy H; Shyr Y; Mohr P; Glantz MJ; Johnson DH
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):157-62. PubMed ID: 10219809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological guideline influence on the therapeutic trend and patient outcome of uterine cervical cancer in Japan: Japan society of gynecologic oncology guideline evaluation committee project.
    Shigeta S; Shida M; Nagase S; Ikeda M; Takahashi F; Shibata T; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
    Gynecol Oncol; 2020 Oct; 159(1):248-255. PubMed ID: 32718728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologists' opinions towards recommending exercise to patients with cancer: a Canadian national survey.
    Jones LW; Courneya KS; Peddle C; Mackey JR
    Support Care Cancer; 2005 Nov; 13(11):929-37. PubMed ID: 15809835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastases.
    Nakamura K; Ishikawa H; Akimoto T; Aoki M; Kariya S; Kawamura H; Kumano T; Kozuka T; Konishi K; Sakaguchi M; Takayama K;
    Jpn J Clin Oncol; 2020 Sep; 50(10):1188-1194. PubMed ID: 32627817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.
    Stewart SL; Townsend JS; Puckett MC; Rim SH
    J Womens Health (Larchmt); 2016 Mar; 25(3):235-41. PubMed ID: 26978124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Referral patterns for gynaecologic cancers and precancerous conditions.
    Gagliardi A; DePetrillo D; Elit L
    J Obstet Gynaecol Can; 2002 Jul; 24(7):553-8. PubMed ID: 12196846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic Counseling of HBOC and Japanese Organization of HBOC].
    Fukushima Y
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):107-110. PubMed ID: 28223668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hereditary breast and ovarian cancer.
    Yamauchi H; Takei J
    Int J Clin Oncol; 2018 Feb; 23(1):45-51. PubMed ID: 29185095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes.
    Brandt AC; Tschirgi ML; Ready KJ; Sun C; Darilek S; Hecht J; Arun BK; Lu KH
    Fam Cancer; 2010 Sep; 9(3):479-87. PubMed ID: 20431955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.